A major breakthrough in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently lost in various types of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research